Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Debt / NOTE 1.250% 5/1
-
Number of holders
-
32
-
Total 13F principal, excl. options
-
217M
-
Principal change
-
-29.4M
-
Total reported value, excl. options
-
$195M
-
Value change
-
-$31.4M
-
Number of buys
-
15
-
Number of sells
-
-11
-
Price
-
$1.04
Significant Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q4 2021
34 filings reported holding 09061GAK7 - BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q4 2021.
BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 has 32 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $217M of principal
.
Largest 10 bondholders include MACKAY SHIELDS LLC ($59.5M of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($43.5M of principal), AQR Arbitrage LLC ($21.7M of principal), Thrivent Financial for Lutherans ($17.7M of principal), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main ($15.7M of principal), STATE STREET CORP ($15.4M of principal), LAZARD ASSET MANAGEMENT LLC ($6.64M of principal), NEW YORK STATE COMMON RETIREMENT FUND ($6.05M of principal), AVIVA PLC ($5M of principal), and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($4.4M of principal).
This table shows the top 32 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.